Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

947 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Downregulation of SIK2 expression promotes the melanogenic program in mice.
Horike N, Kumagai A, Shimono Y, Onishi T, Itoh Y, Sasaki T, Kitagawa K, Hatano O, Takagi H, Susumu T, Teraoka H, Kusano K, Nagaoka Y, Kawahara H, Takemori H. Horike N, et al. Among authors: kusano k. Pigment Cell Melanoma Res. 2010 Dec;23(6):809-19. doi: 10.1111/j.1755-148X.2010.00760.x. Epub 2010 Aug 31. Pigment Cell Melanoma Res. 2010. PMID: 20819186
SIK2 is a key regulator for neuronal survival after ischemia via TORC1-CREB.
Sasaki T, Takemori H, Yagita Y, Terasaki Y, Uebi T, Horike N, Takagi H, Susumu T, Teraoka H, Kusano K, Hatano O, Oyama N, Sugiyama Y, Sakoda S, Kitagawa K. Sasaki T, et al. Among authors: kusano k. Neuron. 2011 Jan 13;69(1):106-19. doi: 10.1016/j.neuron.2010.12.004. Neuron. 2011. PMID: 21220102 Free article.
Irregular Narrow QRS Tachycardia: What Is the Mechanism?
Matsuura H, Kamakura T, Ishiwata M, Kusano K. Matsuura H, et al. Among authors: kusano k. J Cardiovasc Electrophysiol. 2024 Dec 30. doi: 10.1111/jce.16558. Online ahead of print. J Cardiovasc Electrophysiol. 2024. PMID: 39736081 No abstract available.
Population pharmacokinetic and exposure-response analysis to support a dosing regimen of CPX-351 (NS-87) in Japanese adult and pediatric patients with untreated high-risk acute myeloid leukemia.
Imai S, Kitada A, Ogura A, Akagi M, Hasegawa M, Vasilinin G, Marier JF, Wang Q, Ichikawa T, Kusano K. Imai S, et al. Among authors: kusano k. Drug Metab Pharmacokinet. 2024 Nov 16;60:101038. doi: 10.1016/j.dmpk.2024.101038. Online ahead of print. Drug Metab Pharmacokinet. 2024. PMID: 39729780
947 results